CSIMarket
 




Co diagnostics Inc   (CODX)
Other Ticker:  
 
 



CODX Price to Sales Ratio (Dec 31 2023) (Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Sales Trailing 12 Months IV. Quarter III. Quarter II. Quarter I. Quarter IV. Quarter
Price to Sales (TTM) Ratio current            4.75            7.32            4.96            5.46            2.75
Revenue TTM Y / Y Change -80.63 % -91.25 % -90.67 % -87.95 % -65.04 %
Revenue Y / Y Change 140.48 % -51.77 % -96.06 % -97.35 % -93.13 %
Stock performance to date -0.93 % -23.84 % 13.87 % -56.19 % -10.99 %

Price to sales ratio Comment
Company's current Price to sales ratio has decreased due to shareprice contraction of -0.93 %, from beginning of IV. Quarter and despite Revenue increase of 140.48 %, to Price to Sales of 4.75, from average Price to sales ratio in III. Quarter of 7.32.

Within Healthcare sector 24 other companies have lower Price to sales ratio.

What is Price to Sales Ratio?
Sales growth by Co Diagnostics Inc Segment

Price to sales ratio Company Ranking
Within: No.
Industry #9
Sector #25
S&P 500 #458






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com